Literature DB >> 12076113

Development of a clinical syndrome resembling haemorrhagic septicaemia in the buffalo following intravenous inoculation of Pasteurella multocida serotype B:2 endotoxin and the role of tumour necrosis factor-alpha.

N U Horadagoda1, J C Hodgson, G M Moon, T G Wijewardana, P D Eckersall.   

Abstract

Clinical changes and acute phase responses, including tumour necrosis factor-alpha (tnfalpha), in six buffalo calves were examined following intravenous inoculation of a bolus of endotoxin (1 microg kg(-1) bodyweight in 10 ml of phosphate-buffered saline [ pbs ]) extracted from Pasteurella multocida serotype B:2, the bacterium responsible for haemorrhagic septicaemia (hs) in Asia. Endotoxin injection caused a rapid onset of clinical signs characterised by dullness, sternal recumbency, elevated rectal temperatures, excessive salivation and dyspnoea that lasted for up to 12 hours post-inoculation (p.i.). Serum concentrations of tnfalpha rose within 1 hour p.i. to reach peak values ranging between 8 and 140 ng ml(-1) at 1-2 hours p.i. and then declined rapidly to baseline levels 3-5 hours p.i. Endotoxin injection induced other acute phase changes, including a rapid leucopenia and reductions in the serum concentrations of iron and zinc and a delayed but prolonged increase in haptoglobin from 12 hours p.i. that reached a plateau from about 60 hours p.i. Three control calves injected with 10 ml pbs showed no clinical or blood compositional changes. By reproducing key signs of hs the work confirms a pivotal role of endotoxin in the pathogenesis of hs and emphasises the exquisite sensitivity of the buffalo to P multocida endotoxin. Copyright 2002 Published by Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12076113     DOI: 10.1053/rvsc.2001.0538

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  15 in total

1.  Safety and protective efficacy of intramuscular vaccination with a live aroA derivative of Pasteurella multocida B:2 against experimental hemorrhagic septicemia in calves.

Authors:  Mark P Dagleish; J Christopher Hodgson; Saeed Ataei; Anna Finucane; Jeanie Finlayson; Jill Sales; Roger Parton; John G Coote
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

2.  Mouse model of haemorrhagic septicaemia: dissemination and multiplication of Pasteurella multocida B:2 in vital organs after intranasal and subcutaneous challenge in mice.

Authors:  Subhash Kharb; Shiv Charan
Journal:  Vet Res Commun       Date:  2012-12-14       Impact factor: 2.459

3.  Efficacy of vaccination of calves against hemorrhagic septicemia with a live aroA derivative of Pasteurella multocida B:2 by two different routes of administration.

Authors:  J Christopher Hodgson; Anna Finucane; Mark P Dagleish; Saeed Ataei; Roger Parton; John G Coote
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

4.  Protective effect following intranasal exposure of goats to live Pasteurella multocida B:2.

Authors:  M Zamri-Saad; Z A Ernie; M Y Sabri
Journal:  Trop Anim Health Prod       Date:  2006 Oct-Nov       Impact factor: 1.559

5.  The relationship between uterine pathogen growth density and ovarian function in the postpartum dairy cow.

Authors:  E J Williams; D P Fischer; D E Noakes; G C W England; A Rycroft; H Dobson; I M Sheldon
Journal:  Theriogenology       Date:  2007-06-15       Impact factor: 2.740

6.  Effects of milk feeding, frequency and concentration on weaning and buffalo (Bubalus bubalis) calf growth, health and behaviour.

Authors:  Domenico Vecchio; Rossella Di Palo; Esterina De Carlo; Luigi Esposito; Giorgio Antonio Presicce; Alessandra Martucciello; Emilio Chiosi; Pasquale Rossi; Gianluca Neglia; Giuseppe Campanile
Journal:  Trop Anim Health Prod       Date:  2013-05-28       Impact factor: 1.559

7.  Proliferation and transmission patterns of Pasteurella multocida B:2 in goats.

Authors:  M S Shafarin; M Zamri-Saad; B Siti Khairani; A A Saharee
Journal:  Trop Anim Health Prod       Date:  2008-06       Impact factor: 1.559

8.  A heptosyltransferase mutant of Pasteurella multocida produces a truncated lipopolysaccharide structure and is attenuated in virulence.

Authors:  Marina Harper; Andrew D Cox; Frank St Michael; Ian W Wilkie; John D Boyce; Ben Adler
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

9.  The lipopolysaccharide outer core transferase genes pcgD and hptE contribute differently to the virulence of Pasteurella multocida in ducks.

Authors:  Xinxin Zhao; Hui Shen; Sheng Liang; Dekang Zhu; Mingshu Wang; Renyong Jia; Shun Chen; Mafeng Liu; Qiao Yang; Ying Wu; Shaqiu Zhang; Juan Huang; Xumin Ou; Sai Mao; Qun Gao; Ling Zhang; Yunya Liu; Yanling Yu; Leichang Pan; Anchun Cheng
Journal:  Vet Res       Date:  2021-03-04       Impact factor: 3.683

10.  Mass spectrometric analysis of lipid A obtained from the lipopolysaccharide of Pasteurella multocida.

Authors:  Abdul Tawab; Noor Akbar; Mujtaba Hasssan; Fazale Habib; Aamir Ali; Moazur Rahman; Abdul Jabbar; Waqar Rauf; Mazhar Iqbal
Journal:  RSC Adv       Date:  2020-08-20       Impact factor: 4.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.